Testing effectiveness (Phase 2)Study completedNCT03291418
What this trial is testing
To Compare the Gastrointestinal Safety of a 14-Day Oral Dosing Regimen of ATB-346 to Sodium Naproxen in Healthy Subjects
Who this might be right for
Gastric Ulcer
Antibe Therapeutics Inc. 258